ARTICLE | Clinical News
Recombinant IL-7 regulatory update
July 16, 2012 7:00 AM UTC
The European Commission granted Orphan Drug designation for Cytheris' CYT107 to treat progressive multifocal leukoencephalopathy (PML). The company plans to begin a pivotal Phase IIb trial of CYT107 t...